The I-SIGHT study aimed to develop, implement, and evaluate an innovative e-health communication intervention to improve glaucoma treatment compliance among 250 patients recruited from two eye clinics in metropolitan Atlanta. The intervention was telephone-based and utilized interactive voice recognition technology. Further, it was individually-tailored to participants' compliance knowledge, attitudes, and behaviors; health literacy; race and culture; and prescribed medication regimen. This research has the potential to have a significant impact on public health by testing a generalizable and affordable health promotion strategy to increase treatment compliance among diverse populations.
Publications:
Glanz K, Beck AD, Bundy L, Primo S, Lynn MJ, Cleveland J, Wold JA, Echt KV. Impact of a health communication intervention to improve glaucoma treatment adherence: Results of the I-SIGHT Trial. In Press, Archives of Ophthalmology, June 11: 1-7, 2012.
Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC, Glanz K. An Exploratory Study of Factors Influencing Glaucoma Treatment Adherence. Journal of Glaucoma, 19: 66-72, 2010.